Cargando…
Effect of acute iron infusion on insulin secretion: A randomized, double-blind, placebo-controlled trial
BACKGROUND: Chronic exposure to high iron levels increases diabetes risk partly by inducing oxidative stress, but the consequences of acute iron administration on beta cells are unknown. We tested whether the acute administration of iron for the correction of iron deficiency influenced insulin secre...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092517/ https://www.ncbi.nlm.nih.gov/pubmed/35706490 http://dx.doi.org/10.1016/j.eclinm.2022.101434 |
_version_ | 1784705156901765120 |
---|---|
author | Jaccard, Evrim Seyssel, Kévin Gouveia, Alexandre Vergely, Catherine Baratali, Laila Gubelmann, Cédric Froissart, Marc Favrat, Bernard Marques-Vidal, Pedro Tappy, Luc Waeber, Gérard |
author_facet | Jaccard, Evrim Seyssel, Kévin Gouveia, Alexandre Vergely, Catherine Baratali, Laila Gubelmann, Cédric Froissart, Marc Favrat, Bernard Marques-Vidal, Pedro Tappy, Luc Waeber, Gérard |
author_sort | Jaccard, Evrim |
collection | PubMed |
description | BACKGROUND: Chronic exposure to high iron levels increases diabetes risk partly by inducing oxidative stress, but the consequences of acute iron administration on beta cells are unknown. We tested whether the acute administration of iron for the correction of iron deficiency influenced insulin secretion and the production of reactive oxygen species. METHODS: Single-center, double-blinded, randomized controlled trial conducted between June 2017 and March 2020. 32 women aged 18 to 47 years, displaying symptomatic iron deficiency without anaemia, were recruited from a community setting and randomly allocated (1:1) to a single infusion of 1000 mg intravenous ferric carboxymaltose (iron) or saline (placebo). The primary outcome was the between group mean difference from baseline to day 28 in first and second phase insulin secretion, assessed by a two-step hyperglycaemic clamp. All analyses were performed by intention to treat. This trial was registered in ClinicalTrials.gov NCT03191201. FINDINGS: Iron infusion did not affect first and second phase insulin release. For first phase, the between group mean difference from baseline to day 28 was 0 μU × 10 min/mL [95% CI, -22 to 22, P = 0.99]. For second phase, it was -5 μUx10min/mL [95% CI, -161 to 151; P = 0.95] at the first plateau of the clamp and -249 μUx10min/mL [95% CI, -635 to 137; P = 0.20] at the second plateau. Iron infusion increased serum ascorbyl/ascorbate ratio, a marker of plasma oxidative stress, at day 14, with restoration of normal ratio at day 28 relative to placebo. Finally, high-sensitive C-reactive protein levels remained similar among groups. INTERPRETATION: In iron deficient women without anaemia, intravenous administration of 1000 mg of iron in a single sitting did not impair glucose-induced insulin secretion despite a transient increase in the levels of circulating reactive oxygen species. FUNDING: The Swiss National Science Foundation, University of Lausanne and Leenaards, Raymond-Berger and Placide Nicod Foundations. |
format | Online Article Text |
id | pubmed-9092517 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-90925172022-06-14 Effect of acute iron infusion on insulin secretion: A randomized, double-blind, placebo-controlled trial Jaccard, Evrim Seyssel, Kévin Gouveia, Alexandre Vergely, Catherine Baratali, Laila Gubelmann, Cédric Froissart, Marc Favrat, Bernard Marques-Vidal, Pedro Tappy, Luc Waeber, Gérard eClinicalMedicine Articles BACKGROUND: Chronic exposure to high iron levels increases diabetes risk partly by inducing oxidative stress, but the consequences of acute iron administration on beta cells are unknown. We tested whether the acute administration of iron for the correction of iron deficiency influenced insulin secretion and the production of reactive oxygen species. METHODS: Single-center, double-blinded, randomized controlled trial conducted between June 2017 and March 2020. 32 women aged 18 to 47 years, displaying symptomatic iron deficiency without anaemia, were recruited from a community setting and randomly allocated (1:1) to a single infusion of 1000 mg intravenous ferric carboxymaltose (iron) or saline (placebo). The primary outcome was the between group mean difference from baseline to day 28 in first and second phase insulin secretion, assessed by a two-step hyperglycaemic clamp. All analyses were performed by intention to treat. This trial was registered in ClinicalTrials.gov NCT03191201. FINDINGS: Iron infusion did not affect first and second phase insulin release. For first phase, the between group mean difference from baseline to day 28 was 0 μU × 10 min/mL [95% CI, -22 to 22, P = 0.99]. For second phase, it was -5 μUx10min/mL [95% CI, -161 to 151; P = 0.95] at the first plateau of the clamp and -249 μUx10min/mL [95% CI, -635 to 137; P = 0.20] at the second plateau. Iron infusion increased serum ascorbyl/ascorbate ratio, a marker of plasma oxidative stress, at day 14, with restoration of normal ratio at day 28 relative to placebo. Finally, high-sensitive C-reactive protein levels remained similar among groups. INTERPRETATION: In iron deficient women without anaemia, intravenous administration of 1000 mg of iron in a single sitting did not impair glucose-induced insulin secretion despite a transient increase in the levels of circulating reactive oxygen species. FUNDING: The Swiss National Science Foundation, University of Lausanne and Leenaards, Raymond-Berger and Placide Nicod Foundations. Elsevier 2022-05-06 /pmc/articles/PMC9092517/ /pubmed/35706490 http://dx.doi.org/10.1016/j.eclinm.2022.101434 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Articles Jaccard, Evrim Seyssel, Kévin Gouveia, Alexandre Vergely, Catherine Baratali, Laila Gubelmann, Cédric Froissart, Marc Favrat, Bernard Marques-Vidal, Pedro Tappy, Luc Waeber, Gérard Effect of acute iron infusion on insulin secretion: A randomized, double-blind, placebo-controlled trial |
title | Effect of acute iron infusion on insulin secretion: A randomized, double-blind, placebo-controlled trial |
title_full | Effect of acute iron infusion on insulin secretion: A randomized, double-blind, placebo-controlled trial |
title_fullStr | Effect of acute iron infusion on insulin secretion: A randomized, double-blind, placebo-controlled trial |
title_full_unstemmed | Effect of acute iron infusion on insulin secretion: A randomized, double-blind, placebo-controlled trial |
title_short | Effect of acute iron infusion on insulin secretion: A randomized, double-blind, placebo-controlled trial |
title_sort | effect of acute iron infusion on insulin secretion: a randomized, double-blind, placebo-controlled trial |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092517/ https://www.ncbi.nlm.nih.gov/pubmed/35706490 http://dx.doi.org/10.1016/j.eclinm.2022.101434 |
work_keys_str_mv | AT jaccardevrim effectofacuteironinfusiononinsulinsecretionarandomizeddoubleblindplacebocontrolledtrial AT seysselkevin effectofacuteironinfusiononinsulinsecretionarandomizeddoubleblindplacebocontrolledtrial AT gouveiaalexandre effectofacuteironinfusiononinsulinsecretionarandomizeddoubleblindplacebocontrolledtrial AT vergelycatherine effectofacuteironinfusiononinsulinsecretionarandomizeddoubleblindplacebocontrolledtrial AT baratalilaila effectofacuteironinfusiononinsulinsecretionarandomizeddoubleblindplacebocontrolledtrial AT gubelmanncedric effectofacuteironinfusiononinsulinsecretionarandomizeddoubleblindplacebocontrolledtrial AT froissartmarc effectofacuteironinfusiononinsulinsecretionarandomizeddoubleblindplacebocontrolledtrial AT favratbernard effectofacuteironinfusiononinsulinsecretionarandomizeddoubleblindplacebocontrolledtrial AT marquesvidalpedro effectofacuteironinfusiononinsulinsecretionarandomizeddoubleblindplacebocontrolledtrial AT tappyluc effectofacuteironinfusiononinsulinsecretionarandomizeddoubleblindplacebocontrolledtrial AT waebergerard effectofacuteironinfusiononinsulinsecretionarandomizeddoubleblindplacebocontrolledtrial |